US Patent

US9085553 — LFA-1 inhibitor and methods of preparation and polymorph thereof

Formulation · Assigned to Sarcode Bioscience Inc · Expires 2033-07-25 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent discloses methods of preparation and purification of a compound, formulations, and uses thereof in treating LFA-1 mediated diseases.

USPTO Abstract

Methods of preparation and purification of a compound of Formula I, intermediates thereof, a polymorph thereof, and related compounds are disclosed. Formulations and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
US9085553
Jurisdiction
US
Classification
Formulation
Expires
2033-07-25
Drug substance claim
No
Drug product claim
Yes
Assignee
Sarcode Bioscience Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.